Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Recruiting

αβT/B dep-DLIProphylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Sponsor:

University of Wisconsin, Madison

Code:

NCT07285668

Conditions

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-21. This information was provided to ClinicalTrials.gov by University of Wisconsin, Madison on 2026-02-02.